Skip to main content
Tag

Sai Nandi Archives - BioHealth Innovation

From Science to Patient-First Investing: Sai Nandi on Immune Boost Capital and Autoimmune Innovation on BioTalk

By BioTalk with Rich Bendis Podcast, News

In this episode of BioTalk with Rich Bendis, Sai Nandi, D.Phil., Founding Principal of Immune Boost Capital (IBC), joins the conversation to discuss how mission-driven investing can help bridge the gap between scientific discovery, company formation, and new treatments for patients with autoimmune diseases.

Sai shares his journey from a small mining town in rural India to Oxford University, Cold Spring Harbor Laboratory, and senior investment roles managing large healthcare portfolios. He discusses how his experience as both a scientist and investor shaped his approach to evaluating early-stage technologies, supporting founders, and moving promising research toward commercialization.

Listen now via your favorite podcast platforms:
Apple: https://apple.co/4eF44Ss
Spotify: https://bit.ly/4zmWnZo
iHeart: https://ihr.fm/3W8MVub
YouTube: https://bit.ly/4eMHhEj
Amazon: https://amzn.to/3W8N2WD
TuneIn: https://bit.ly/4ihgDFT

The conversation explores Immune Boost Capital, the philanthropic venture investment arm of the Arthritis National Research Foundation, and its evergreen investment model. Sai explains how IBC combines early-stage capital, scientific expertise, and company-building support to advance autoimmune innovation, including its first investment in Orthrus Therapeutics and the growing opportunities for more precise, patient-focused treatments.

Rich and Sai also discuss lessons from New York’s life sciences ecosystem, the challenges of attracting early-stage investment, and opportunities to strengthen the BioHealth Capital Region. Having recently relocated to Montgomery County, Maryland, Sai shares his perspective on connecting regional research institutions, entrepreneurs, investors, and organizations like BHI and TEDCO to help more promising technologies reach the market.

The episode closes with a look at the future of autoimmune innovation, the importance of mission-driven capital, and how stronger connections between science, investment, and talent can support the next generation of life sciences companies.

Editing and post-production work for this episode was provided by The Podcast Consultant.

About Sai Nandi, D.Phil.

Sai Nandi, D.Phil., is Founding Principal of Immune Boost Capital, where he leads the firm’s strategic vision and oversees its venture investment portfolio. He is an experienced life sciences investor and operator with more than two decades of leadership spanning venture capital, institutional investing, and company building. Previously, he served as a Portfolio Manager at AIG Investments and held senior investment roles at global asset management firms, managing public and private healthcare portfolios exceeding $1 billion. He has held executive leadership positions, including Chief Business Officer at Oryzon, and served on the boards of more than 10 biotechnology and healthcare technology companies, advising on financing, mergers and acquisitions, business development, and clinical operations. His experience includes work with Roivant Sciences, BridgeBio Pharma, ElevateBio, Cullinan Therapeutics, Fractyl Health, AlloVir, SQZ Biotech, and Atomwise. Sai earned his D.Phil. in Biochemistry from the University of Oxford as an SKP Clarendon Scholar and served as a Visiting Scientist at Cold Spring Harbor Laboratory, where he received the NCI NYSTAR Fellowship. His scientific research has been published in Science, Nature, and Molecular Cell.

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.